Electronic Tracking Success Could End Rx-Only Pseudoephedrine In Mississippi
This article was originally published in The Tan Sheet
Former Mississippi Gov. Haley Barbour says industry should ask state legislators to repeal the 2010 law that made all PSE drugs Rx-only. CHPA “might get some listeners” if it highlights how the tracking system places less of a financial burden on consumers and the health care system, he says.
You may also be interested in...
Legislators in Kentucky debate requiring a prescription for purchase of OTC pseudoephedrine over monthly and annual limits, while Oklahoma lawmakers consider requiring pharmacists to determine a patient’s need. CHPA opposes further limits on access and promotes electronic tracking with stop-sale technology.
Research shows Rx requirements “do not effectively reduce methamphetamine’s overall impact on a given state,” CHPA President Scott Melville says. One study found Oregon’s Rx-only law has not dramatically reduced meth lab incidents compared to other states and the second showed the requirement would cost Oklahoma $59 million annually.
Mississippi lawmakers' decision to make all pseudoephedrine-containing drugs prescription-only will not prompt other states combating methamphetamine to do the same, the Consumer Healthcare Products Association predicts